Lam Research Balance Sheet Health
Financial Health criteria checks 6/6
Lam Research has a total shareholder equity of $8.0B and total debt of $5.0B, which brings its debt-to-equity ratio to 62.1%. Its total assets and total liabilities are $18.3B and $10.3B respectively. Lam Research's EBIT is $4.1B making its interest coverage ratio 85.6. It has cash and short-term investments of $5.7B.
Key information
62.1%
Debt to equity ratio
US$4.98b
Debt
Interest coverage ratio | 85.6x |
Cash | US$5.67b |
Equity | US$8.02b |
Total liabilities | US$10.26b |
Total assets | US$18.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LRCX's short term assets ($12.5B) exceed its short term liabilities ($4.4B).
Long Term Liabilities: LRCX's short term assets ($12.5B) exceed its long term liabilities ($5.8B).
Debt to Equity History and Analysis
Debt Level: LRCX has more cash than its total debt.
Reducing Debt: LRCX's debt to equity ratio has reduced from 89.4% to 62.1% over the past 5 years.
Debt Coverage: LRCX's debt is well covered by operating cash flow (98.6%).
Interest Coverage: LRCX's interest payments on its debt are well covered by EBIT (85.6x coverage).